Boston Scientific Announces Canadian Approval and Launch of PROMUS Element™ Plus Stent System

NATICK, Mass., April 24, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces CE Mark and European market launch of the Emerge™ PTCA[1] Dilatation Catheter.  The Emerge Catheter is ...

Boston Scientific Corp.’s Cognis and Teligen defibrillators, used to shock a stopped heart back into a normal rhythm, may have a flaw that can cause the device to heat up and has been linked to one death, said Rick Wise, an analyst with Leerink Swann Co.

Boston Scientific Corp.’s Cognis/Teligen defibrillator, used to shock a stopped heart back into a normal rhythm, may have a flaw that can cause the device to heat up and has been linked to one death, said Rick Wise, an analyst with Leerink Swann Co. An electrical transformer has shown a “pattern of malfunction,” Wise said in a note to clients, citing Boston Scientific’s Product Performance ...

NATICK, Mass., April 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute ...